Over-the-counter drug · OTC MONOGRAPH DRUG
Geri-kot (Standardized senna concentrate) NDC 71335-1806
Sennosides 8.6 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-1806-1 | 7133518060171335180601 | 100 TABLET in 1 BOTTLE (71335-1806-1)Marketed from Mar 15, 2021 | |
| 71335-1806-2 | 7133518060271335180602 | 60 TABLET in 1 BOTTLE (71335-1806-2)Marketed from Jul 9, 2021 | |
| 71335-1806-3 | 7133518060371335180603 | 120 TABLET in 1 BOTTLE (71335-1806-3)Marketed from Jun 27, 2025 | |
| 71335-1806-4 | 7133518060471335180604 | 56 TABLET in 1 BOTTLE (71335-1806-4)Marketed from Jun 27, 2025 | |
| 71335-1806-5 | 7133518060571335180605 | 30 TABLET in 1 BOTTLE (71335-1806-5)Marketed from Jun 4, 2021 | |
| 71335-1806-6 | 7133518060671335180606 | 90 TABLET in 1 BOTTLE (71335-1806-6)Marketed from Jun 27, 2025 | |
| 71335-1806-7 | 7133518060771335180607 | 10 TABLET in 1 BOTTLE (71335-1806-7)Marketed from Jun 27, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Geri-kot
- Generic name (nonproprietary)
- standardized senna concentrate
- Active ingredients
- Sennosides — 8.6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch PrepackNDC labeler code 71335
- Product type
- Over-the-counter drug
- Marketing category
- OTC monograph drugApplication 505G(a)(3)
- Marketing start
- Listing expires
- Identifiers
- Product ID 71335-1806_13d8f467-0a7f-4773-ad5f-1666f14cb84fSPL ID 13d8f467-0a7f-4773-ad5f-1666f14cb84fSPL set ID 13d8f467-0a7f-4773-ad5f-1666f14cb84fRxCUI 312935UNII 3FYP5M0IJX
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335180601followed by a unit qualifier and the quantityPackage 71335-1806-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours
Excerpt only. Read the full label for complete information.
About NDC 71335-1806
- What is NDC 71335-1806?
- 71335-1806 is the product NDC for Geri-kot (standardized senna concentrate), Sennosides 8.6 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Geri-kot (Standardized Senna Concentrate).
- What is the active ingredient?
- Sennosides.
- Who is the labeler?
- Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Geri-kot?
- 2 other product NDCs are listed under this name. See all Geri-kot NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Geri-kot products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Geri-kotsennosides | Sennosides 8.6 mg/1 | TabletOral | Geri-Care Pharmaceutical Corp | 57896-434 | 57896-0434-0157896-0434-1057896-0434-20 |
| Geri-kotstandardized senna concentrate | Sennosides 8.6 mg/1 | TabletOral | Geri-Care Pharmaceutical Corp | 57896-454 | 57896-0454-20 |
Other NDCs under 505G(a)(3)
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
Showing 20 of 40.